merck & co. - Search News

News

Merck, vaccine and Robert F. Kennedy Jr.

RFK Jr.’s New Vaccine Panel Includes Two Paid Witnesses Against Merck

Two new vaccine advisers tapped by Health and Human Services Secretary Robert F. Kennedy Jr. have served as paid expert witnesses for plaintiffs suing Merck & Co. over some of the drug company’s inoculations targeting measles,

· 4d

RFK Jr. Appointee To CDC Advisory Committee Was A Paid Expert In Merck's Gardasil Lawsuit

· 4d · on MSN

Exclusive-Kennedy's new vaccine adviser was expert witness against Merck vaccine

1don MSN

Goldman Sachs Remains a Buy on Merck & Co (MRK), Sets a $99.00 PT

Merck & Co., Inc. (NYSE:MRK) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Analyst Asad Haider from ...

10h

Merck Manuals Launches AI-powered Search Tool, Providing Enhanced Access to Trusted Medical Information and Resources

Merck Manuals, a comprehensive digital health resource, announced today it has launched a new search tool enhanced by artificial intelligence to provide patients and other health care consumers with ...

Fierce Biotech7d

Merck's leader in oral PCSK9 inhibitor race reduces cholesterol in pair of phase 3 trials

Merck & Co.’s ambition to get the first oral PCSK9 inhibitor to market came one step closer this morning as the pharma ...

Fierce Pharma7d

Feeling RSV heat from Merck, Sanofi lays out early supply plans for Beyfortus

One day before the potential FDA approval of a rival respiratory syncytial virus (RSV) monoclonal antibody from Merck & Co., ...

Merck & Co. Inc. stock outperforms competitors on strong trading day

Merck & Co. Inc. closed 39.23% short of its 52-week high of $134.63, which the company reached on June 25th.

Merck Wins US Approval for Shot to Prevent Infant RSV

Merck & Co. said it won US approval for a shot that protects against RSV, the most common cause of hospitalization among ...

Explore more

Food and Drug Administration

Pembrolizumab

Unpacking the Latest Options Trading Trends in Merck & Co

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

The Motley Fool: Merck’s risks and potential

There’s reason to remain bullish about Merck’s growth prospects in the long run. And at a discounted price, the stock could ...

Morningstar3d

Merck & Co Inc MRK

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BioPharma Dive7d

Merck antibody drug for RSV approved by FDA

Known as Enflonsia, the drug will compete for market share with Sanofi and AstraZeneca’s in-demand Beyfortus, which quickly ...

InvestorsHub on MSN4d

Merck Launches Final-Stage Trial of Dengue Vaccine for Children

Merck & Co Inc (NYSE:MRK) has begun a Phase 3 clinical trial to test its experimental dengue vaccine in a pediatric ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results